Breaking News
Get 50% Off 0
📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-Earnings Read more
Close

GSK plc (GSKl)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,520.50 -10.75    -0.70%
19/07 - Closed. Currency in GBP ( Disclaimer )
  • Volume: 490,492
  • Bid/Ask: 1,522.50 / 1,522.50
  • Day's Range: 1,504.00 - 1,526.00
Type:  Equity
Market:  Euro Zone
ISIN:  GB00BN7SWP63 
GSK plc 1,520.50 -10.75 -0.70%

GSKl Ratios

 
Use this page to view Glaxo key financial ratios such as their Price-to-Earnings (P/E Ratio), Earnings-Per-Share (EPS), Return-On-Investment (ROI) and others based on the latest GSK financial reports.
Advanced Ratios
Name Company Industry
   
P/E Ratio TTM 13.92 40.65
Price to Sales TTM 2.03 10.79
Price to Cash Flow MRQ 10.79 26.7
Price to Free Cash Flow TTM 9.84 29.79
Price to Book MRQ 4.51 21.44
Price to Tangible Book MRQ -7.09 42.11
   
Profitability: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Gross margin TTM 72.67% 82.03
Gross Margin 5YA 68.78% 60.47
Operating margin TTM 28.39% 34.41
Operating margin 5YA 25.05% -1.09
Pretax margin TTM 17.93% 31.14
Pretax margin 5YA 18.93% 832.52
Net Profit margin TTM 14.59% 25.63
Net Profit margin 5YA 25.18% 828.01
   
Revenue/Share TTM 7.52 43.72
Basic EPS ANN 1.22 12.18
Diluted EPS ANN 1.2 12.13
Book Value/Share MRQ 3.39 26.51
Tangible Book Value/Share MRQ -2.16 0.66
Cash/Share MRQ 0.68 3.69
Cash Flow/Share TTM 1.88 16.57
   
Management Effectiveness: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Return on Equity TTM 34.95% 54.42
Return on Equity 5YA 44.23% 48.17
Return on Assets TTM 8.13% 19.11
Return on Assets 5YA 10.33% 18.4
Return on Investment TTM 25.12% 42.2
Return on Investment 5YA 16.71% 40.8
   
EPS(MRQ) vs Qtr. 1 Yr. Ago MRQ -30.23% 34.75
EPS(TTM) vs TTM 1 Yr. Ago TTM -69.57% 56.14
5 Year EPS Growth 5YA 5.7% 15.97
Sales (MRQ) vs Qtr. 1 Yr. Ago MRQ 5.93% 22.11
Sales (TTM) vs TTM 1 Yr. Ago TTM 5.69% 17.85
5 Year Sales Growth 5YA -0.32% 14.17
5 Year Capital Spending Growth 5YA -0.45% 14.1
   
Quick Ratio MRQ 0.55 0.56
Current Ratio MRQ 0.87 0.89
LT Debt to Equity MRQ 109.51% 35.13
Total Debt to Equity MRQ 128.41% 49.12
Efficiency    
Asset Turnover TTM 0.52 0.67
Inventory Turnover TTM 1.52 1.44
Revenue/Employee TTM 437.82K 2.32M
Net Income/Employee TTM 67.77K 741.97K
Receivable Turnover TTM 4.62 4.65
   
Dividend Yield ANN 3.91% 1.2
Dividend Yield 5 Year Avg. 5YA 6.51% 2.26
Dividend Growth Rate ANN -26.89% 5.09
Payout Ratio TTM 50.4% 52.16
TTM = Trailing Twelve Months  5YA = 5-Year Average  MRQ = Most Recent Quarter
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced valuation and financial ratios for in-depth analysis of company financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GSK Price Commentary

Write your thoughts about GSK plc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ka Boom
Ka Boom May 10, 2024 12:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will it exceed 1800 and stay their is the question
Ka Boom
Ka Boom May 10, 2024 12:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
more enough 5 year high. now will it smash through that high is the question.....
Reshad Chesson
Reshad Chesson Jan 31, 2024 13:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nov 1 call coming correct
Pavel Marchenko
Pavel Marchenko Jan 10, 2024 8:31
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thanks
Reshad Chesson
Reshad Chesson Jan 09, 2024 15:57
Saved. See Saved Items.
This comment has already been saved in your Saved Items
did anyone act on my call.
Reshad Chesson
Reshad Chesson Nov 01, 2023 16:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
triple buy. tgt 1900
John Ford
John Ford Jan 24, 2023 15:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
All export earners today are going south
Dan Morris
Dan Morris Dec 07, 2022 13:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lovely little boost from the Zantec case today. Let's hope the shares kick onwards from here
איציק צארלי
איציק צארלי Nov 28, 2022 16:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ITH stock
Anon Anon
Anon Anon Nov 11, 2022 16:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bought back all the gsk that I sold back in May. It's a no brainer at this price
Anon Anon
Anon Anon Nov 11, 2022 16:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buying GSK is like investing in a junk bond. One need to buy when the yield is high
Mike Bamber
Mike Bamber Nov 11, 2022 16:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
. Well, yield is OK as long as it's not offset by value destruction through capital loss. In GSKs case as long as Walmsley is at the helm you can guarantee value destruction. She couldn't develop a blockbuster drug or vaccine if her life depended on it. Pascal Sorrel at Astra Zenrcca must be laughing his head off at this train crash of a CEO
Anon Anon
Anon Anon Nov 11, 2022 16:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You are right. Also the price has been range bound for a decade and we are now near to the lower bound. I've heard similar comments to you nearly ever year when it's price is underperforming
Mike Bamber
Mike Bamber Nov 11, 2022 16:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I wish the institutional shareholders would wake up and do something about the management team. Surely with such an abysmal performance over so long GSK must be a takeover target?
Anon Anon
Anon Anon Nov 11, 2022 16:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I'm only interested in swing trading this counter. If the price doesn't move I'll just collect dividends while waiting for it to bounce. The spinoff of Haleon is a good move as in this day and age companies need to be pure play to get ahead of competition. Consumer healthcare business was a distraction to their management.
John Hamilton
John Hamilton Nov 11, 2022 12:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
new management required
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email